Sernova Biotherapeutics Inc
Stock
Stock
ISIN: CA81752F1062
Ticker: SVA
CA81752F1062
SVA
Price
Price
CHART BY
Frequently asked questions
What is Sernova Biotherapeutics Inc's market capitalization?
The market capitalization of Sernova Biotherapeutics Inc is $36.79M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Sernova Biotherapeutics Inc?
Sernova Biotherapeutics Inc's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0212. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sernova Biotherapeutics Inc's stock?
Currently, 2 analysts cover Sernova Biotherapeutics Inc's stock, with a consensus target price of $0.722. Analyst ratings provide insights into the stock's expected performance.
What is the EBITDA for Sernova Biotherapeutics Inc?
Sernova Biotherapeutics Inc's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$6.37M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Sernova Biotherapeutics Inc?
Sernova Biotherapeutics Inc has a free cash flow of -$3.19M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Sernova Biotherapeutics Inc have, and what sector and industry does it belong to?
Sernova Biotherapeutics Inc employs approximately 8 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Sernova Biotherapeutics Inc's shares?
The free float of Sernova Biotherapeutics Inc is 327.09M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $36.79M
- EPS (TTM)
- -$0.0212
- Free Float
- 327.09M
- EBITDA (TTM)
- -$6.37M
- Free Cashflow (TTM)
- -$3.19M
Pricing
- 1D span
- $0.0951$0.106
- 52W span
- $0.0719$0.145
Analyst Ratings
The price target is $0.722 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. It focuses on its proprietary Cell Pouch, a bio-hybrid organ system which is designed to enhance the delivery of cell therapy to better replicate natural body functions. The company was founded on August 19, 1998 and is headquartered in London, Canada.
- Employees
- 8
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- CA81752F1062
- Primary Ticker
- SVA
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet